查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949664

2026年全球水凝膠藥物遞送系統市場報告

Hydrogel Based Drug Delivery System Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，以水凝膠為基礎的藥物遞送系統市場發展迅速，預計將從2025年的75.6億美元成長到2026年的83.6億美元，複合年成長率達10.6%。過去幾年的成長要素包括水凝膠配方選擇有限、對天然水凝膠的高度依賴、臨床應用率低、聚合物藥物遞送系統短缺以及對緩釋治療方法的需求不斷成長。

預計未來幾年，以水凝膠為基礎的藥物遞送系統市場將快速成長，到2030年市場規模將達到123.5億美元，複合年成長率（CAGR）為10.2%。預測期內的成長要素包括合成水凝膠和混合水凝膠的開發、對腫瘤學和心臟病學領域日益成長的關注、注射和眼科給藥途徑的拓展、個性化水凝膠療法的日益普及以及對研究機構和醫院投資的增加。預測期內的主要趨勢包括：注射和局部應用的水凝膠藥物遞送系統日益普及、水凝膠在靶向腫瘤學和心臟病學治療中的應用日益廣泛、用於改善藥物釋放特性的混合水凝膠的開發、肽、蛋白質和聚合物藥物遞送研究的拓展以及個性化醫療和患者特異性藥物製劑的發展。

預計未來燒燙傷發生率的上升將推動水凝膠藥物遞送系統市場的發展。燒燙傷是指皮膚和深層組織因熱、化學物質、電或輻射而受損。此類病例的增加主要是由於家庭事故中涉及熱液體和烹飪用具造成的，這凸顯了提高日常安全意識的重要性。水凝膠藥物遞送系統透過創造濕潤的保護性環境來促進燒燙傷癒合。這可以加速癒合、減輕疼痛，並以可控、持續的方式輸送藥物，從而支持組織修復並預防感染。例如，根據總部位於美國的國際燒傷損傷資料庫（iBID）於2023年10月發布的報告，2023年上半年兒童燒燙傷和燙傷病例較去年同期增加了45%，成人和老年人因熱水袋造成的燒傷病例也增加了19%。因此，燒燙傷病例的增加趨勢正在推動對水凝膠藥物遞送系統的需求。

水凝膠藥物遞送市場的主要企業正致力於研發先進創新技術，例如可注射水凝膠，這種技術能夠實現更精準的標靶遞送和可控的持續藥物釋放。可注射水凝膠是一種柔軟、富含水分的材料，可透過微創方式給藥，將藥物直接釋放到靶點，從而提高療效並減少副作用。例如，2024年10月，總部位於芬蘭的生技公司UPM Biomedicals Oy推出了Fibgel，這是全球首款專為永久植入式醫療設備設計的可注射奈米纖維素水凝膠。 Fibgel由可再生芬蘭樺木纖維素和水製成，是一種安全、永續且不含動物源成分的替代合成水凝膠和動物源水凝膠的產品。其可調的機械性能和優異的生物相容性使其能夠在標靶實現可控的藥物釋放。其剪切稀化特性使其在微創手術中易於注射，從而提高患者的舒適度並加快康復速度。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球水凝膠藥物遞送系統市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 注射式和外用水凝膠藥物傳遞系統的應用日益廣泛
    • 水凝膠在標靶腫瘤治療和心臟治療的應用日益廣泛
    • 開發用於增強藥物釋放曲線的混合水凝膠
    • 拓展胜肽、蛋白質和大分子藥物傳遞方面的研究
    • 個人化醫療和病患特異性藥物製劑的發展

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 研究所
  • 製藥公司
  • 學術和臨床研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球水凝膠藥物遞送系統市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球水凝膠藥物遞送系統市場規模、比較及成長率分析
  • 全球水凝膠藥物遞送系統市場表現：規模與成長，2020-2025年
  • 全球水凝膠藥物遞送系統市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 按水凝膠類型
  • 天然水凝膠、合成水凝膠、混合水凝膠
  • 依藥物類型
  • 低分子量化合物、高分子量化合物、胜肽、蛋白質
  • 透過行政途徑
  • 外用、注射、口服、經皮、眼用
  • 透過使用
  • 心臟病學、腫瘤學、免疫學、疼痛管理及其他應用領域
  • 最終用戶
  • 醫院、診所、研究機構和其他最終用戶
  • 按類型細分：天然水凝膠
  • 海藻酸鹽、幾丁聚醣、膠原蛋白、明膠、玻尿酸、纖維蛋白
  • 按類型細分：合成水凝膠
  • 聚乙二醇（PEG）、聚乙烯醇（PVA）、聚丙烯醯胺（PAAm）、泊洛沙姆、聚（N-異丙基丙烯醯胺）（PNIPAM）
  • 按類型細分：混合水凝膠
  • 天然及合成聚合物共混物、互穿聚合物網路（IPN）、複合水凝膠、奈米複合水凝膠

第10章 區域與國家分析

  • 全球水凝膠藥物傳遞系統市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球水凝膠藥物遞送系統市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 水凝膠藥物遞送系統市場：競爭格局及市場佔有率（2024年）
  • 水凝膠藥物遞送系統市場：公司估值矩陣
  • 水凝膠藥物遞送系統市場：公司概況
    • Johnson & Johnson
    • Merck KGaA
    • UPM Biomedicals Oy
    • The Lubrizol Corporation
    • Ashland Global Holdings Inc.

第37章：其他領先和創新企業

  • B. Braun Melsungen AG, Ocular Therapeutix Inc., Primex ehf, Heppe Medical Chitosan GmbH, BioCat GmbH, Micropore Technologies Limited, Akina Inc., KitoZyme SA

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年水凝膠藥物遞送系統市場：蘊藏新機會的國家
  • 2030年水凝膠藥物遞送系統市場：充滿新機會的細分市場
  • 2030年水凝膠藥物遞送系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: PH5MHBDD01_G26Q1

A hydrogel-based drug delivery system consists of a network of hydrophilic polymers that can absorb and retain large amounts of water while maintaining a gel-like structure. This system enables controlled and sustained drug release at targeted sites within the body, improving drug stability, bioavailability, and patient compliance through precise dosing and reduced side effects.

The main types of hydrogels used in hydrogel-based drug delivery systems are natural hydrogels, synthetic hydrogels, and hybrid hydrogels. Natural hydrogels are water-absorbing materials derived from natural polymers that mimic living tissue, supporting biocompatible, controlled drug delivery and tissue healing. These hydrogels can carry various types of drugs, including small molecules, large molecules, peptides, and proteins, and are administered through multiple routes, such as topical, injectable, oral, transdermal, and ocular. They are applied in areas including cardiology, oncology, immunology, pain management, and more, serving end users such as hospitals, clinics, research institutes, and others.

Tariffs have impacted the hydrogel-based drug delivery system market by increasing the cost of imported polymers, excipients, and specialized equipment used in hydrogel synthesis and formulation. Segments like synthetic and hybrid hydrogels are most affected, particularly in Asia-Pacific and North American regions that rely heavily on imports. While tariffs have increased production costs and slowed supply chains, they have also encouraged domestic manufacturing, innovation in polymer blends, and development of cost-effective hydrogel solutions.

The hydrogel based drug delivery system market research report is one of a series of new reports from The Business Research Company that provides hydrogel based drug delivery system market statistics, including hydrogel based drug delivery system industry global market size, regional shares, competitors with a hydrogel based drug delivery system market share, detailed hydrogel based drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the hydrogel based drug delivery system industry. This hydrogel based drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hydrogel based drug delivery system market size has grown rapidly in recent years. It will grow from $7.56 billion in 2025 to $8.36 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to limited hydrogel formulations, reliance on natural hydrogels, low adoption in clinical settings, lack of large molecule delivery systems, growing demand for sustained release therapies.

The hydrogel based drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $12.35 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of synthetic and hybrid hydrogels, increasing focus on oncology and cardiology applications, expansion of injectable and ocular delivery routes, rising adoption of personalized hydrogel therapies, growing investment in research institutes and hospitals. Major trends in the forecast period include rising adoption of injectable and topical hydrogel drug delivery systems, increasing use of hydrogels for targeted oncology and cardiology therapies, development of hybrid hydrogels for enhanced drug release profiles, expansion of research on peptides, proteins, and large molecule delivery, growth in personalized medicine and patient-specific drug formulations.

The increasing number of burn cases is expected to drive the expansion of the hydrogel-based drug delivery system market in the future. Burns occur when the skin or deeper tissues are damaged by heat, chemicals, electricity, or radiation. The rise in such cases is largely due to household accidents involving hot liquids or cooking equipment, highlighting the importance of greater safety awareness in everyday activities. Hydrogel-based drug delivery systems aid burn recovery by creating a moist, protective environment that speeds up healing, reduces pain, and delivers medications in a controlled, sustained manner to support tissue repair and prevent infection. For example, in October 2023, the International Burn Injury Database (iBID), a US-based organization, reported that in the first half of 2023, burns and scalds among children rose by 45% compared to the same period in 2022, while incidents among adults and the elderly from hot water bottles increased by 19%. As a result, the growing prevalence of burn cases is fueling demand for hydrogel-based drug delivery systems.

Key companies in the hydrogel-based drug delivery market are focusing on advanced innovations such as injectable hydrogels to improve targeted delivery and enable controlled, sustained drug release. Injectable hydrogels are soft, water-rich materials administered minimally invasively, allowing drugs to be released directly at the target site with enhanced effectiveness and fewer side effects. For instance, in October 2024, UPM Biomedicals Oy, a biotechnology company based in Finland, introduced Fibgel, the world's first injectable nanocellulose hydrogel designed for permanent implantable medical devices. Made from renewable Finnish birch wood cellulose and water, Fibgel provides a safe, sustainable, and animal-free alternative to synthetic and animal-derived hydrogels. It offers tunable mechanical properties and strong biocompatibility, enabling controlled drug release at the target site. Its shear-thinning nature allows easy injection through minimally invasive procedures, improving patient comfort and speeding recovery.

In May 2025, AmacaThera Inc., a Canadian biotechnology company specializing in sustained-release hydrogel technologies, partnered with Merck Animal Health USA LLC to advance hydrogel-based drug delivery in veterinary medicine. Through this collaboration, Merck Animal Health USA LLC seeks to expand its veterinary portfolio by utilizing AmacaThera's hydrogel platform to develop long-acting, sustained-release formulations that enhance animal health and welfare, providing veterinarians and pet owners with more effective and convenient treatment options. Merck Animal Health USA LLC is a US-based animal healthcare company.

Major companies operating in the hydrogel based drug delivery system market are Johnson & Johnson, Merck KGaA, UPM Biomedicals Oy, The Lubrizol Corporation, Ashland Global Holdings Inc., B. Braun Melsungen AG, Ocular Therapeutix Inc., Primex ehf, Heppe Medical Chitosan GmbH, BioCat GmbH, Micropore Technologies Limited, Akina Inc., KitoZyme SA

North America was the largest region in the hydrogel-based drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hydrogel based drug delivery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hydrogel based drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hydrogel-based drug delivery system market consists of sales of periodontal hydrogels, hydrogel-based microneedle patches, hydrogel-coated drug-eluting stents, hydrogel-based tissue adhesive systems, and hydrogel-encapsulated cell or gene delivery systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hydrogel Based Drug Delivery System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hydrogel based drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hydrogel based drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hydrogel based drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type Of Hydrogel: Natural Hydrogels; Synthetic Hydrogels; Hybrid Hydrogels
  • 2) By Drug Type: Small Molecules; Large Molecules; Peptides; Proteins
  • 3) By Route Of Administration: Topical; Injectable; Oral; Transdermal; Ocular
  • 4) By Application: Cardiology; Oncology; Immunology; Pain Management; Other Applications
  • 5) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Natural Hydrogels: Alginate; Chitosan; Collagen; Gelatin; Hyaluronic Acid; Fibrin
  • 2) By Synthetic Hydrogels: Polyethylene Glycol (PEG); Polyvinyl Alcohol (PVA); Polyacrylamide (PAAm); Poloxamer; Poly(N-isopropylacrylamide) (PNIPAM)
  • 3) By Hybrid Hydrogels: Natural-Synthetic Polymer Blends; Interpenetrating Polymer Networks (IPNs); Composite Hydrogels; Nanocomposite Hydrogels
  • Companies Mentioned: Johnson & Johnson; Merck KGaA; UPM Biomedicals Oy; The Lubrizol Corporation; Ashland Global Holdings Inc.; B. Braun Melsungen AG; Ocular Therapeutix Inc.; Primex ehf; Heppe Medical Chitosan GmbH; BioCat GmbH; Micropore Technologies Limited; Akina Inc.; KitoZyme SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hydrogel Based Drug Delivery System Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hydrogel Based Drug Delivery System Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hydrogel Based Drug Delivery System Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hydrogel Based Drug Delivery System Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Injectable And Topical Hydrogel Drug Delivery Systems
    • 4.2.2 Increasing Use Of Hydrogels For Targeted Oncology And Cardiology Therapies
    • 4.2.3 Development Of Hybrid Hydrogels For Enhanced Drug Release Profiles
    • 4.2.4 Expansion Of Research On Peptides, Proteins, And Large Molecule Delivery
    • 4.2.5 Growth In Personalized Medicine And Patient-Specific Drug Formulations

5. Hydrogel Based Drug Delivery System Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Research Institutes
  • 5.4 Pharmaceutical Companies
  • 5.5 Academic And Clinical Laboratories

6. Hydrogel Based Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hydrogel Based Drug Delivery System Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hydrogel Based Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hydrogel Based Drug Delivery System Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hydrogel Based Drug Delivery System Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hydrogel Based Drug Delivery System Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hydrogel Based Drug Delivery System Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hydrogel Based Drug Delivery System Market Segmentation

  • 9.1. Global Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Natural Hydrogels, Synthetic Hydrogels, Hybrid Hydrogels
  • 9.2. Global Hydrogel Based Drug Delivery System Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Small Molecules, Large Molecules, Peptides, Proteins
  • 9.3. Global Hydrogel Based Drug Delivery System Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Topical, Injectable, Oral, Transdermal, Ocular
  • 9.4. Global Hydrogel Based Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiology, Oncology, Immunology, Pain Management, Other Applications
  • 9.5. Global Hydrogel Based Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Research Institutes, Other End-Users
  • 9.6. Global Hydrogel Based Drug Delivery System Market, Sub-Segmentation Of Natural Hydrogels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Alginate, Chitosan, Collagen, Gelatin, Hyaluronic Acid, Fibrin
  • 9.7. Global Hydrogel Based Drug Delivery System Market, Sub-Segmentation Of Synthetic Hydrogels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polyethylene Glycol (PEG), Polyvinyl Alcohol (PVA), Polyacrylamide (PAAm), Poloxamer, Poly(N-isopropylacrylamide) (PNIPAM)
  • 9.8. Global Hydrogel Based Drug Delivery System Market, Sub-Segmentation Of Hybrid Hydrogels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Natural-Synthetic Polymer Blends, Interpenetrating Polymer Networks (IPNs), Composite Hydrogels, Nanocomposite Hydrogels

10. Hydrogel Based Drug Delivery System Market Regional And Country Analysis

  • 10.1. Global Hydrogel Based Drug Delivery System Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hydrogel Based Drug Delivery System Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hydrogel Based Drug Delivery System Market

  • 11.1. Asia-Pacific Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hydrogel Based Drug Delivery System Market

  • 12.1. China Hydrogel Based Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hydrogel Based Drug Delivery System Market

  • 13.1. India Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hydrogel Based Drug Delivery System Market

  • 14.1. Japan Hydrogel Based Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hydrogel Based Drug Delivery System Market

  • 15.1. Australia Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hydrogel Based Drug Delivery System Market

  • 16.1. Indonesia Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hydrogel Based Drug Delivery System Market

  • 17.1. South Korea Hydrogel Based Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hydrogel Based Drug Delivery System Market

  • 18.1. Taiwan Hydrogel Based Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hydrogel Based Drug Delivery System Market

  • 19.1. South East Asia Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hydrogel Based Drug Delivery System Market

  • 20.1. Western Europe Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hydrogel Based Drug Delivery System Market

  • 21.1. UK Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hydrogel Based Drug Delivery System Market

  • 22.1. Germany Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hydrogel Based Drug Delivery System Market

  • 23.1. France Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hydrogel Based Drug Delivery System Market

  • 24.1. Italy Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hydrogel Based Drug Delivery System Market

  • 25.1. Spain Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hydrogel Based Drug Delivery System Market

  • 26.1. Eastern Europe Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hydrogel Based Drug Delivery System Market

  • 27.1. Russia Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hydrogel Based Drug Delivery System Market

  • 28.1. North America Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hydrogel Based Drug Delivery System Market

  • 29.1. USA Hydrogel Based Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hydrogel Based Drug Delivery System Market

  • 30.1. Canada Hydrogel Based Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hydrogel Based Drug Delivery System Market

  • 31.1. South America Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hydrogel Based Drug Delivery System Market

  • 32.1. Brazil Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hydrogel Based Drug Delivery System Market

  • 33.1. Middle East Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hydrogel Based Drug Delivery System Market

  • 34.1. Africa Hydrogel Based Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hydrogel Based Drug Delivery System Market, Segmentation By Type Of Hydrogel, Segmentation By Drug Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hydrogel Based Drug Delivery System Market Regulatory and Investment Landscape

36. Hydrogel Based Drug Delivery System Market Competitive Landscape And Company Profiles

  • 36.1. Hydrogel Based Drug Delivery System Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hydrogel Based Drug Delivery System Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hydrogel Based Drug Delivery System Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. UPM Biomedicals Oy Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. The Lubrizol Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Ashland Global Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Hydrogel Based Drug Delivery System Market Other Major And Innovative Companies

  • B. Braun Melsungen AG, Ocular Therapeutix Inc., Primex ehf, Heppe Medical Chitosan GmbH, BioCat GmbH, Micropore Technologies Limited, Akina Inc., KitoZyme SA

38. Global Hydrogel Based Drug Delivery System Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hydrogel Based Drug Delivery System Market

40. Hydrogel Based Drug Delivery System Market High Potential Countries, Segments and Strategies

  • 40.1 Hydrogel Based Drug Delivery System Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hydrogel Based Drug Delivery System Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hydrogel Based Drug Delivery System Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer